PIN5 THE COST EFFECTIVENESS ANALYSIS OF TREATMENT WITH PEGINTERFERON ALFA-2A (40KD) IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B

Effectiveness Analysis ◽

Peginterferon Alfa ◽

The Cost ◽

PIN67 Cost-Effectiveness Analysis of Peginterferon Alfa-2A (40KD) in HBEAG-Negative Chronic Hepatitis B in Poland

Value in Health ◽

10.1016/j.jval.2011.08.253 ◽

2011 ◽

Vol 14 (7) ◽

pp. A277

Author(s):

M. Jakubczyk ◽

J. Pawèska ◽

M. Niewada ◽

H. Berak ◽

M. Szkultecka-dèbek ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Effectiveness Analysis ◽

Peginterferon Alfa ◽

PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA

Value in Health ◽

10.1016/s1098-3015(11)72842-x ◽

2010 ◽

Vol 13 (7) ◽

pp. A438

Author(s):

W Chen

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Effectiveness Analysis ◽

Positive Chronic Hepatitis ◽

Peginterferon Alfa

PID21: THE COST-EFFECTIVENESS ANALYSIS OF LAMIVUDINE IN THE TREATMENT OF CHRONIC HEPATITIS B IN POLAND

Value in Health ◽

10.1046/j.1524-4733.2001.40202-179.x ◽

2001 ◽

Vol 4 (2) ◽

pp. 136

Author(s):

E Orlewska

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Effectiveness Analysis ◽

The Cost

Cost-effectiveness analysis of lamivudine and adefovir dipivoxil in the treatment of patients with HBeAg-negative chronic hepatitis B

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2006.02767.x ◽

2006 ◽

Vol 23 (3) ◽

pp. 409-419 ◽

Cited By ~ 14

Author(s):

M. BUTI ◽

M. A. CASADO ◽

J. L. CALLEJA ◽

J. SALMERON ◽

J. AGUILAR ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Adefovir Dipivoxil ◽

Effectiveness Analysis ◽

The Cost Effectiveness Analysis Of The Oral Anti-Viral Treatments Alternatives For The Chronic Hepatitis B In Turkey

Value in Health ◽

10.1016/j.jval.2014.08.823 ◽

2014 ◽

Vol 17 (7) ◽

pp. A367

Author(s):

G. Kockaya ◽

A. Kose ◽

C. Dalgic ◽

F.B. Yenilmez ◽

O. Ozdemir ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Effectiveness Analysis ◽

The Cost

PIN31 COST-EFFECTIVENESS ANALYSIS OF TELBIVUDINE VS LAMIVUDINE IN TREATING THE PATIENTS WITH HBEAG-POSITIVE AND -NEGATIVE CHRONIC HEPATITIS B IN CHINA

Value in Health ◽

10.1016/s1098-3015(10)75089-0 ◽

2009 ◽

Vol 12 (7) ◽

pp. A423 ◽

Cited By ~ 1

Author(s):

W Chen ◽

J Hou

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Effectiveness Analysis ◽

A Cost-Utility and Cost-Effectiveness Analysis of Different Oral Antiviral Medications in Patients With HBeAg-Negative Chronic Hepatitis B in Iran: An Economic Microsimulation Decision Model

Hepatitis Monthly ◽

10.5812/hepatmon.37435 ◽

2016 ◽

Vol 16 (9) ◽

Cited By ~ 1

Author(s):

Khosro Keshavarz ◽

Abbas Kebriaeezadeh ◽

Seyed Moayed Alavian ◽

Ali Akbari Sari ◽

Mohsen Rezaei Hemami ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Decision Model ◽

Cost Utility ◽

Effectiveness Analysis ◽

Antiviral Medications ◽

Evaluating anti-viral drug selection and treatment duration in HBeAg-negative chronic hepatitis B: a cost-effectiveness analysis

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2008.03691.x ◽

2008 ◽

Vol 27 (12) ◽

pp. 1240-1252 ◽

Cited By ~ 22

Author(s):

D. L. VEENSTRA ◽

D. E. SPACKMAN ◽

A. BISCEGLIE ◽

K. V. KOWDLEY ◽

R. G. GISH

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Treatment Duration ◽

Drug Selection ◽

Effectiveness Analysis ◽

PIN15 COST-EFFECTIVENESS ANALYSIS OF 1-YEAR PEGINTERFERON ALFA-2A VERSUS 3 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA

Value in Health ◽

10.1016/s1098-3015(11)73295-8 ◽

2010 ◽

Vol 13 (7) ◽

pp. A549

Author(s):

W Chen

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Effectiveness Analysis ◽

Positive Chronic Hepatitis ◽

Peginterferon Alfa

Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom

Value in Health ◽

10.1016/j.jval.2015.05.007 ◽

2015 ◽

Vol 18 (6) ◽

pp. 800-809 ◽

Cited By ~ 10

Author(s):

Sarah L. Bermingham ◽

Ralph Hughes ◽

Elisabetta Fenu ◽

Laura M. Sawyer ◽

Elizabeth Boxall ◽

...

Keyword(s):

Chronic Hepatitis ◽

United Kingdom ◽

Cost Effectiveness ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

The United Kingdom ◽

Effectiveness Analysis ◽